BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 12551867)

  • 1. Acute intravenous L-arginine infusion decreases endothelin-1 levels and improves endothelial function in patients with angina pectoris and normal coronary arteriograms: correlation with asymmetric dimethylarginine levels.
    Piatti P; Fragasso G; Monti LD; Setola E; Lucotti P; Fermo I; Paroni R; Galluccio E; Pozza G; Chierchia S; Margonato A
    Circulation; 2003 Jan; 107(3):429-36. PubMed ID: 12551867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial and metabolic characteristics of patients with angina and angiographically normal coronary arteries: comparison with subjects with insulin resistance syndrome and normal controls.
    Piatti P; Fragasso G; Monti LD; Caumo A; Van Phan C; Valsecchi G; Costa S; Fochesato E; Pozza G; Pontiroli AE; Chierchia S
    J Am Coll Cardiol; 1999 Nov; 34(5):1452-60. PubMed ID: 10551692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nebivolol therapy improves endothelial function and increases exercise tolerance in patients with cardiac syndrome X.
    Sen N; Tavil Y; Erdamar H; Yazici HU; Cakir E; Akgül EO; Bilgi C; Erbil MK; Poyraz F; Okyay K; Turfan M; Cemri M
    Anadolu Kardiyol Derg; 2009 Oct; 9(5):371-9. PubMed ID: 19819787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelium-dependent vasodilation is independent of the plasma L-arginine/ADMA ratio in men with stable angina: lack of effect of oral L-arginine on endothelial function, oxidative stress and exercise performance.
    Walker HA; McGing E; Fisher I; Böger RH; Bode-Böger SM; Jackson G; Ritter JM; Chowienczyk PJ
    J Am Coll Cardiol; 2001 Aug; 38(2):499-505. PubMed ID: 11499744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma asymmetric dimethylarginine and L-arginine levels in patients with cardiac syndrome X.
    Okyay K; Cengel A; Sahinarslan A; Tavil Y; Turkoglu S; Biberoglu G; Hasanoglu A
    Coron Artery Dis; 2007 Nov; 18(7):539-44. PubMed ID: 17925607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term angiotensin-converting enzyme inhibition reduces plasma asymmetric dimethylarginine and improves endothelial nitric oxide bioavailability and coronary microvascular function in patients with syndrome X.
    Chen JW; Hsu NW; Wu TC; Lin SJ; Chang MS
    Am J Cardiol; 2002 Nov; 90(9):974-82. PubMed ID: 12398965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of asymmetric dimethylarginine (ADMA) concentrations during coronary circulation in patients with vasospastic angina.
    Hori T; Matsubara T; Ishibashi T; Ozaki K; Tsuchida K; Mezaki T; Tanaka T; Nasuno A; Kubota K; Nakamura Y; Yamazoe M; Aizawa Y; Nishio M
    Circ J; 2003 Apr; 67(4):305-11. PubMed ID: 12655160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carotid intima-media thickness in patients with cardiac syndrome X and its association with high circulating levels of asymmetric dimethylarginine.
    Sen N; Poyraz F; Tavil Y; Yazici HU; Turfan M; Hizal F; Topal S; Erdamar H; Cakir E; Yalçin R; Cengel A
    Atherosclerosis; 2009 Jun; 204(2):e82-5. PubMed ID: 19010468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia.
    Böger RH; Bode-Böger SM; Szuba A; Tsao PS; Chan JR; Tangphao O; Blaschke TF; Cooke JP
    Circulation; 1998 Nov; 98(18):1842-7. PubMed ID: 9799202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of insulin infusion on endothelium-derived vasoactive substances.
    Polderman KH; Stehouwer CD; van Kamp GJ; Gooren LJ
    Diabetologia; 1996 Nov; 39(11):1284-92. PubMed ID: 8932993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased levels of asymmetric dimethylarginine during acute hyperinsulinemia.
    Eid HM; Reims H; Arnesen H; Kjeldsen SE; Lyberg T; Seljeflot I
    Metabolism; 2007 Apr; 56(4):464-9. PubMed ID: 17379002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired flow-mediated dilation with age is not explained by L-arginine bioavailability or endothelial asymmetric dimethylarginine protein expression.
    Gates PE; Boucher ML; Silver AE; Monahan KD; Seals DR
    J Appl Physiol (1985); 2007 Jan; 102(1):63-71. PubMed ID: 16946027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of low-dose heparin infusion on arterial endothelin-1 release in humans.
    Piatti PM; Monti LD; Valsecchi G; Conti M; Nasser R; Guazzini B; Fochesato E; Phan CV; Pontiroli AE; Pozza G
    Circulation; 1996 Dec; 94(11):2703-7. PubMed ID: 8941092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of growth hormone treatment on arginine to asymmetric dimethylarginine ratio and endothelial function in patients with growth hormone deficiency.
    Setola E; Monti LD; Lanzi R; Lucotti P; Losa M; Gatti E; Galluccio E; Oldani M; Fermo I; Giovannelli M; Bosi E; Piatti P
    Metabolism; 2008 Dec; 57(12):1685-90. PubMed ID: 19013291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased insulin-stimulated endothelin-1 release is a distinct vascular phenotype distinguishing Cushing's disease from metabolic syndrome.
    Setola E; Losa M; Lanzi R; Lucotti P; Monti LD; Castrignanò T; Galluccio E; Giovanelli M; Piatti P
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):586-92. PubMed ID: 17371479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma endothelin levels and vascular effects of intravenous L-arginine infusion in subjects with uncomplicated insulin-dependent diabetes mellitus.
    Smulders RA; Stehouwer CD; Olthof CG; van Kamp GJ; Teerlink T; de Vries PM; Donker AJ
    Clin Sci (Lond); 1994 Jul; 87(1):37-43. PubMed ID: 8062517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asymmetric dimethylarginine, L-arginine, and endothelial dysfunction in essential hypertension.
    Perticone F; Sciacqua A; Maio R; Perticone M; Maas R; Boger RH; Tripepi G; Sesti G; Zoccali C
    J Am Coll Cardiol; 2005 Aug; 46(3):518-23. PubMed ID: 16053968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does acute improvement of endothelial dysfunction in coronary artery disease improve myocardial ischemia? A double-blind comparison of parenteral D- and L-arginine.
    Quyyumi AA
    J Am Coll Cardiol; 1998 Oct; 32(4):904-11. PubMed ID: 9768710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-arginine infusion induces hypotension and diuresis/natriuresis with concomitant increased urinary excretion of nitrite/nitrate and cyclic GMP in humans.
    Kanno K; Hirata Y; Emori T; Ohta K; Eguchi S; Imai T; Marumo F
    Clin Exp Pharmacol Physiol; 1992 Sep; 19(9):619-25. PubMed ID: 1327594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asymmetric dimethylarginine determines the improvement of endothelium-dependent vasodilation by simvastatin: Effect of combination with oral L-arginine.
    Böger GI; Rudolph TK; Maas R; Schwedhelm E; Dumbadze E; Bierend A; Benndorf RA; Böger RH
    J Am Coll Cardiol; 2007 Jun; 49(23):2274-82. PubMed ID: 17560293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.